Rheumnow Podcast
by Dr. Cush
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 16 chart positions in 16 markets.
By chart position
- 🇺🇸US · Medicine#1885K to 30K
- 🇧🇷BR · Medicine#9210K to 30K
- 🇯🇵JP · Medicine#1171K to 10K
- 🇮🇳IN · Medicine#1481K to 10K
- 🇲🇽MX · Medicine#1511K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
14K to 57K🎙 Daily cadence·999 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
46K to 191K🇺🇸16%🇧🇷16%🇦🇷16%+13 more - Active Followers
Loyal subscribers who consistently listen
14K to 57K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 33 epsHosts
Recent guests
Recent episodes
Seronegative RA Disease Activity (7.17.2026)
Jul 17, 2026
21m 27s
What Lies Beneath - Uric Acid Deposition & Imaging
Jul 15, 2026
59m 52s
Gout QD clinics - lessons from the Clinic QD307-QD311
Jul 13, 2026
38m 00s
Gout Cavalcade (7.10.2026)
Jul 10, 2026
27m 13s
Gout Journal Club
Jul 8, 2026
57m 26s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/17/26 | Rheumatoid ArthritisDisease Activity+3 | — | RheumNow.com | — | Rheumatoid ArthritisGout+3 | — | 21m 27s | ||
| 7/15/26 | goutimaging+4 | Dr. Nicola DalbethDr. John Fitzgerald+1 | Rheumnow Podcast | — | goutimaging+5 | — | 59m 52s | ||
| 7/13/26 | goutallopurinol+3 | — | QD307: Senior Year GoutQD308: Allopurinol for All Gout? Not Quite+3 | — | goutallopurinol+3 | — | 38m 00s | ||
| 7/10/26 | gouthealth news+3 | — | Rheumnow | — | gouthealth+3 | — | 27m 13s | ||
| 7/8/26 | gouturate-lowering treatment+4 | Abhishek Abhishek, MD, PhD, MBBS, FRCPZeqin Wen, MD+4 | JAMA Internal MedicineTreat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients with Gout+1 | — | gouturate-lowering+4 | — | 57m 26s | ||
| 7/7/26 | Rheumatoid ArthritisTNFi failure+4 | Dr. Christina Charles-SchoemanDr. Manish Jain | Rheumnow Podcast | — | Rheumatoid ArthritisTNFi+5 | AbbVie Medical Affairs | 17m 16s | ||
| 7/3/26 | presentation skillslecturing+3 | — | — | — | presentationlectures+3 | — | 27m 45s | ||
| 6/26/26 | tofacitinibCAR-T therapy+3 | — | TofacitinibCAR-T therapy+1 | — | tofacitinibCAR-T therapy+3 | — | 30m 23s | ||
| 6/26/26 | dermatologyPsoriasis+4 | — | tofacitinibBimekizumab+3 | — | PsoriasisPsA+7 | — | 17m 43s | ||
| 6/19/26 | zoster vaccinationEULAR 2026+3 | — | — | — | zoster vaccineEULAR+3 | — | 29m 24s | ||
| 6/12/26 | rheumatologyEULAR 2026+3 | Arthur Kavanaugh | EULAR | London | rheumatologyEULAR 2026+3 | — | 56m 02s | ||
| 6/11/26 | rheumatoid arthritistreatment strategies+4 | Dr. Bella MehtaJanet Pope+1 | EULARrheumatoid arthritis | — | rheumatoid arthritistreatment+4 | — | 54m 22s | ||
| 6/10/26 | CAR-Ttreatment strategies+4 | Alfred KimJanet Pope+1 | EULAR | — | CAR-Ttreatment+4 | — | 38m 02s | ||
| 6/9/26 | psoriatic arthritisEULAR 2026+4 | Peter NashAntoni Chan+1 | EULARPsA | — | psoriatic arthritisEULAR 2026+5 | — | 48m 42s | ||
| 6/8/26 | Rheumatoid ArthritisWomen's Health+4 | — | BlinatumomabMethotrexate+8 | — | Rheumatoid ArthritisBlinatumomab+6 | — | 1h 34m 30s | ||
| 6/8/26 | Psoriatic ArthritisWomen's Health+5 | — | bDMARDsJAKis+2 | — | PsAEULAR+8 | — | 1h 36m 32s | ||
| 6/8/26 | CAR-T therapyRheumatoid Arthritis+4 | — | CAR-TEULAR | — | CAR-TRheumatoid Arthritis+5 | — | 31m 55s | ||
| 6/8/26 | PsA Disease SpectrumInflammatory Arthritis+3 | — | GuselkumabBaricitinib+2 | — | GuselkumabPsA+7 | — | 24m 54s | ||
| 6/7/26 | Rheumatoid ArthritisInterstitial Lung Disease+3 | — | EULAR | — | RA-ILDAI+5 | — | 20m 34s | ||
| 6/7/26 | bDMARDsJAK inhibitors+4 | — | bDMARDsJAKis+5 | — | bDMARDsJAK inhibitors+6 | — | 32m 53s | ||
| 5/8/26 | rheumatologynews+3 | — | rheumnow.com | — | rheumatoid factorsrheumatology+3 | — | 22m 20s | ||
| 5/1/26 | presentation skillslecturing+3 | — | — | — | presentationlectures+3 | — | 27m 45s | ||
| 5/1/26 | dermatologypsoriasis+5 | — | SkyriziTremfya+2 | Asia-Pacific | dermatologyPsoriasis+6 | — | 15m 43s | ||
| 4/24/26 | rheumatologyfinance+3 | — | — | — | rheumatologyfinance+3 | — | 25m 58s | ||
| 4/17/26 | rheumatologymedical news+3 | — | RheumNow.com | — | rheumatologymedical news+3 | — | 25m 05s |
Showing 25 of 25
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Rheumnow Podcast
Peaked at #31 in AR, currently #31 in AR.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| AR | — | #31 | #31 | — |
| TH | — | #44 | #44 | — |
| HU | — | #58 | #58 | — |
| Brazil | — | #92 | #92 | — |
| CZ | — | #109 | #109 | — |
| Japan | — | #117 | #117 | — |
| CH | — | #130 | #130 | — |
| CO | — | #131 | #131 | — |
| IL | — | #144 | #144 | — |
| CL | — | #144 | #144 | — |
| India | — | #148 | #148 | — |
| Mexico | — | #151 | #151 | — |
| South Korea | — | #154 | #154 | — |
| Denmark | — | #175 | #175 | — |
| PT | — | #180 | #180 | — |
| United States | — | #188 | #188 | — |
Chart Positions
16 placements across 16 markets.
Chart Positions
16 placements across 16 markets.